Skip to main content
. 2018 Oct 26;10(1):153–158. doi: 10.3892/mco.2018.1752

Table I.

Primary cancer.

Case Age, years Histology Site Chemotherapy, cumulative doses Radiation
1 4 Medulloblastoma Cerebellar vermis VCR, 0.6 mg/m2, CPM, 12,000 mg/m2 Yes
CDDP, 360 mg/m2, VP16, 14,000 mg/m2 32 Gy (brain)
TEPA, 800 mg/m2, LPAM, 280 mg/m2, 18 Gy (spine)
MTX (intrathecal injection), 72 mg/body
2 9 Germ cell tumor Anterior mediastinum IFM, 18 g/m2, CBDCA, 4,500 mg/m2 None
CDDP, 400 mg/m2, VP-16, 5,100 mg/m2
BLM, 45 mg/m2, PTX, 650 mg/m2
3 1 Anaplastic astrocytoma Medulla oblongata VCR, CPM, CDDP, VP-16, TEPA, L-PAM Yes
(Cumulative doses are not applicable) 40 Gy (brain)

VCR, vincristine; CPM, cyclophosphamide; CDDP, cisplatin; VP16, etoposide; TEPA, thiotepa; LPAM, melphalan; MTX, methotrexate; IFM, ifosfamide; CBDCA, carboplatin; BLM, bleomycin; PTX, paclitaxel.